無導線暫停製造商市場：按產品類型、類別、最終用戶和地區分類

Leadless Pacemakers Market, By Product Type, By Type, By End User, By Geography

出版日期: 2026年03月31日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，無導線心律調節器市場規模為 9.151 億美元，到 2033 年將達到 22.618 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 13.8%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	9.151億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	13.80%	2033年市場規模預測：	22.618億美元

無導線心律調節器是一種先進的心臟節律器，它透過大腿或經皮途徑植入心臟，而不是透過胸部切口。與傳統心律調節器（其導線從心律調節器延伸至心臟並植入胸部皮下）不同，無導線心律調節器直接植入心臟，無需導線。這帶來了許多優勢，例如減少了與心律調節器導線相關的併發症，並提高了患者進行磁振造影(MRI) 檢查的兼容性。隨著電子設備小型化技術的進步和電池壽命的延長，無導線心律調節器在治療心搏過緩方面越來越受歡迎。預計未來幾年全球需求將顯著成長。

市場動態

全球無導線心律調節器市場成長的主要促進因素包括：全球老年人口不斷增加，心血管疾病風險日益升高；心律調節器系統小型化技術不斷進步；以及無導線系統相比傳統心律調節器所具有的優勢，例如併發症減少和與磁振造影(MRI) 兼容。然而，無導線心律調節器成本較高以及電池壽命問題限制了市場發展。各公司推出的電池壽命更長的全無導線心律調節器系統為市場帶來了巨大的成長機會。從區域來看，北美和歐洲等已開發市場目前佔據主導地位，但亞太地區的新興市場預計將在未來幾年帶來巨大的成長潛力。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數對全球無導線心律調節器市場的主要參與者進行了分析：公司概況、產品系列、主要亮點、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、型號升級、市場擴張和行銷策略做出明智的決策。
這份全球無導線心律調節器市場報告的目標受群眾外包括行業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過對全球無導線心律調節器市場進行分析時所使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第8章競爭情勢

Abbott Laboratories
Medtronic PLC
Boston Scientific Corporation
EBR Systems Inc.
MicroPort Scientific Corporation
Biotronik SE & Co. KG
Jude Medical（now part of Abbott）
Osypka AG
Lepu Medical Technology
Cardiac Rhythm Management（CRM）
AtriCure Inc.
Cook Medical
Sorin Group
Biotronik
Neovasc Inc.

第9章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第10章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI7725

Leadless Pacemakers Market is estimated to be valued at USD 915.1 Mn in 2026 and is expected to reach USD 2,261.8 Mn by 2033, growing at a compound annual growth rate (CAGR) of 13.8% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 915.1 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	13.80%	2033 Value Projection:	USD 2,261.8 Mn

Leadless pacemakers are advanced cardiac pacemakers that are implanted via femoral or trans-cutaneous access in the heart rather than through incisions in the chest. Unlike traditional pacemakers that are implanted under the skin in the chest with wires running from the pacemaker to the heart, leadless pacemakers are directly implanted in the heart and have no wires. They offer advantages such as reducing complications related to pacemaker leads and enabling more compatibility with magnetic resonance imaging (MRI) scans for patients. With advancements in miniaturization of electronics and improvements in battery life, leadless pacemakers are increasingly gaining popularity for treatment of bradycardia. Their global demand is projected to grow substantially in the coming years.

Market Dynamics

The global leadless pacemakers market is driven by rising geriatric population worldwide that is susceptible to cardiovascular diseases, technological advancements enabling miniaturization of pacemaker systems, and benefits offered by leadless systems over traditional pacemakers such as reducing complications and enabling Magnetic Resonance Imaging, MRI compatibility. However, high cost of leadless pacemakers compared to traditional ones and issues regarding battery longevity act as restraints for the market. Introduction of completely leadless pacing systems with improved battery life by players presents a major growth opportunity. Regionally, developed markets in North America and Europe currently dominate the market but emerging countries in Asia Pacific are expected to provide high growth opportunities in the coming years.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global leadless pacemakers market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, EBR Systems Inc., MicroPort Scientific Corporation, Biotronik SE & Co. KG, St. Jude Medical (now part of Abbott), Osypka AG, Lepu Medical Technology, Cardiac Rhythm Management (CRM), AtriCure Inc., Cook Medical, Sorin Group, Biotronik, and Neovasc Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global leadless pacemakers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global leadless pacemakers market.

Market Segmentation

Product Type Insights (Revenue, USD Mn, 2021 - 2033)
Micra Transcatheter Pacing System
Nanostim Leadless Pacemaker
Other Leadless Pacemakers
Type Insights (Revenue, USD Mn, 2021 - 2033)
Single Chamber
Dual Chamber
End User Insights (Revenue, USD Mn, 2021 - 2033)
Hospitals
Ambulatory Surgical Centers
long-term care facilities
Others
Regional Insights (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Abbott Laboratories
Medtronic PLC
Boston Scientific Corporation
EBR Systems Inc.
MicroPort Scientific Corporation
Biotronik SE & Co. KG
Jude Medical (now part of Abbott)
Osypka AG
Lepu Medical Technology
Cardiac Rhythm Management (CRM)
AtriCure Inc.
Cook Medical
Sorin Group
Biotronik
Neovasc Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Leadless Pacemakers Market, By Product Type
- Global Leadless Pacemakers Market, By Type
- Global Leadless Pacemakers Market, By End User
- Global Leadless Pacemakers Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends

4. Global Leadless Pacemakers Market, By Product Type, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Micra Transcatheter Pacing System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Nanostim Leadless Pacemaker
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Other Leadless Pacemakers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

5. Global Leadless Pacemakers Market, By Type, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Single Chamber
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Dual Chamber
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

6. Global Leadless Pacemakers Market, By End User, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
long-term care facilities
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

7. Global Leadless Pacemakers Market, By Region, 2021 - 2033, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2026,2028 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Medtronic PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Boston Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
EBR Systems Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
MicroPort Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Biotronik SE & Co. KG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Jude Medical (now part of Abbott)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Osypka AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Lepu Medical Technology
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cardiac Rhythm Management (CRM)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AtriCure Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cook Medical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sorin Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Biotronik
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Neovasc Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies